Wedbush Increases Earnings Estimates for Ascendis Pharma A/S
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Wedbush upped their FY2029 earnings per share (EPS) estimates for Ascendis Pharma A/S in a research note issued to investors on Wednesday, February 12th. Wedbush analyst Y. Zhong now expects that the biotechnology company will post earnings of $14.13 per share for the year, up […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Wedbush upped their FY2029 earnings per share (EPS) estimates for Ascendis Pharma A/S in a research note issued to investors on Wednesday, February 12th. Wedbush analyst Y. Zhong now expects that the biotechnology company will post earnings of $14.13 per share for the year, up […]
